|1.||Whitley, Richard J: 3 articles (03/2012 - 10/2004)|
|2.||Honma, Y: 3 articles (09/2001 - 01/2000)|
|3.||Baljinnyam, Erdene: 2 articles (02/2014 - 06/2012)|
|4.||Vatner, Stephen F: 2 articles (02/2014 - 06/2012)|
|5.||Vatner, Dorothy E: 2 articles (02/2014 - 06/2012)|
|6.||Kurokawa, Masahiko: 2 articles (01/2005 - 09/2004)|
|7.||Kurosaki, Kunikazu: 2 articles (01/2005 - 09/2004)|
|8.||Shiraki, Kimiyasu: 2 articles (01/2005 - 09/2004)|
|9.||Yoshida, Yoshihiro: 2 articles (01/2005 - 09/2004)|
|10.||Miwa, Naoko: 2 articles (01/2005 - 09/2004)|
08/01/1977 - "Treatment with ARA-A begun as late as 7 days after virus infection was significantly effective in preventing death; no antiviral effect of the other two drugs was demonstrated."
10/01/1983 - "Because of the recently published data on experience with the antiviral agent vidarabine, early diagnosis of this infection becomes imperative if enhanced therapeutic efficacy is to be achieved. "
05/01/1975 - "Herpesvirus hominis infection in newborn mice: comparison of the therapeutic efficacy of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyladenine."
09/01/1983 - "Ara-A therapy begun at the 3rd day of infection clearly increased the survival rate (90%) and improved the clinical signs, but the start of the drug at the 6th day could only increase the survival rate (60%) without cure of the clinical symptoms. "
01/01/1987 - "On the basis of our current study and previous trials in hepatitis B virus-infected patients, we predict that adenine arabinoside will not efficiently eliminate viral replication in chronic hepadna virus infection, when used as the sole therapeutic modality. "
04/01/1977 - "Adenine arabinoside is most effective against disseminated herpes simplex virus and disseminated herpes zoster. "
10/14/1982 - "We conducted a double-blind, placebo-controlled trial to assess the value of vidarabine therapy for the prevention of complications from herpes zoster in immunocompromised patients. "
05/15/1985 - "Vidarabine therapy for herpes zoster."
02/15/1985 - "Neurotoxic effects during vidarabine therapy for herpes zoster."
12/01/1983 - "Herpes zoster patients may benefit from treatment with vidarabine, currently the only antiviral agent approved for use in this disease. "
|3.||Encephalitis (Encephalitis, Rasmussen)
02/01/1985 - "Ara-A provided protection against HSV-1 encephalitis in immunosuppressed mice inoculated with a low dose (200 PFU/mouse) of MMUdRR virus or wild-type HSV-1. "
07/01/1981 - "In this last article of a four-part series, the authors review clinical studies that have to date led to the licensing of ara-A for HSV encephalitis but have not yet clearly defined its role in the immunosuppressed or in neonates."
02/01/1998 - "Herpetic brainstem encephalitis was diagnosed, and he received 900 mg/day vidarabine. "
02/01/1990 - "In our view ara-A treatment should be taken in consideration in case of acute encephalitis unresponsive to Acv."
09/01/1983 - "The effect of Ara-A treatment on the experimentally induced herpes simplex virus (HSV) encephalitis in rabbits was examined. "
10/01/1975 - "The relative efficacy of ara-A was also determined against type 2 herpes and vaccinia virus-induced keratitis. "
10/01/1981 - "[Use of adenine-arabinoside in the treatment of keratitis: study of 70 cases]."
02/15/2014 - "Vidarabine was the first clinically approved antiviral drug, but due to safety and efficacy issues the drug is currently only used topically for herpes virus keratitis. "
01/01/1990 - "Indications of Ara-A during ocular herpes are superficial keratitis, especially those resistant to IDU or, from experimental data, to ACV, and their prevention by a possible long term treatment."
08/01/1976 - "Treatment of vaccinial keratitis with vidarabine."
|5.||Herpes Simplex Encephalitis (Herpes Encephalitis)
02/05/1981 - "To learn more about the treatment of herpes simplex encephalitis with vidarabine, we conducted an uncontrolled study of 132 patients referred to 22 hospitals because of suspected disease. "
02/01/1983 - "Recurrent herpes simplex encephalitis: recovery of virus after Ara-A treatment."
09/01/1982 - "[Early adenine arabinoside therapy in herpes simplex encephalitis (HSE)]."
04/01/1982 - "Herpes simplex encephalitis: poor outcome despite adenine arabinoside therapy."
02/01/1982 - "Herpes simplex encephalitis (HSE) is associated with high mortality and morbidity, but these rates may be reduced by early administration of vidarabine. "
|8.||DNA (Deoxyribonucleic Acid)
|2.||Drug Therapy (Chemotherapy)
|3.||Home Nursing (Nursing, Home)